Related Experiment Video
Updated: Aug 11, 2026

Encapsulation and Permeability Characteristics of Plasma Polymerized Hollow Particles
Published on: August 16, 2012
Intercalation and controlled release of pharmaceutically active compounds from a layered double hydroxide
A I Khan1, L Lei, A J Norquist
1Inorganic Chemistry Laboratory, South Parks Road, Oxford, UK OX1 3QR.
Layered double hydroxides can reversibly intercalate pharmaceutical compounds like ibuprofen and naproxen. These findings suggest a new tunable drug delivery system for various medications.
Area of Science:
- Materials Science
- Pharmaceutical Science
- Nanotechnology
Background:
- Layered double hydroxides (LDHs) are recognized for their anion exchange capabilities.
- Drug delivery systems aim for controlled and targeted release of active pharmaceutical ingredients.
- Intercalation into nanomaterials offers a promising route for drug stabilization and delivery.
Purpose of the Study:
- To investigate the intercalation of various pharmaceutically active compounds into layered double hydroxides.
- To evaluate the potential of these intercalated materials as a novel drug delivery system.
- To explore the tuneability of drug loading and release characteristics.
Main Methods:
- Synthesis of layered double hydroxide materials.
- Reversible intercalation of model pharmaceutical compounds (e.g., diclofenac, ibuprofen, naproxen).
- Characterization of intercalated compounds using techniques like X-ray diffraction and spectroscopy.
Main Results:
- Successful reversible intercalation of multiple pharmaceutical compounds into the LDH structure was achieved.
- Evidence suggests the formation of a stable drug-LDH composite.
- Initial studies indicate the potential for controlled release applications.
Conclusions:
- Layered double hydroxides can serve as effective hosts for a range of pharmaceutical agents.
- The developed intercalation method offers a foundation for a novel, tuneable drug delivery platform.
- Further research is warranted to optimize drug loading and release kinetics for therapeutic applications.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Rate-Programmed I
Oral Drug Delivery Systems: Delayed-Release Systems

